A Knockout Punch for Pediatric Brain Tumors? Targeting DIPG with Nanotechnology

Despite decades of clinical trials to find effective therapies the prognosis for children with diffuse intrinsic pontine glioma (DIPG), a pediatric brain tumor, remains grim. Generally diagnosed before age ten, most DIPG patients survive less than one year.

More at Progressnotes, MUSC’s Medical Magazine